Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 2:1
Phase 3:1
Drug Approvals
1
FDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 3
1 (50.0%)Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2023-07-06
- Lead Sponsor
- Dermavant Sciences, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT05186805
- Locations
- 🇨🇦
Dermavant Investigative Site, Calgary, Alberta, Canada
Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults
Phase 3
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: Vehicle cream
- First Posted Date
- 2021-08-20
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Dermavant Sciences, Inc.
- Target Recruit Count
- 407
- Registration Number
- NCT05014568
- Locations
- 🇨🇦
Dermavant Investigative Site, Montréal, Quebec, Canada
News
No news found